Professional
Added to YB: 2023-04-22
Pitch date: 2023-04-22
TALS [bullish]
Talaris Therapeutics, Inc.
+11.48%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of October 19, 2023, Talaris Therapeutics, Inc. was acquired by Tourmaline Bio, Inc., in a reverse merger transaction.
Market Cap
$116.4M
Pitch Price
$10.84
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.52
P/E
-1.82
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Talaris Therapeutics (TALS) - Potential Liquidation - 25%+ Upside
A summary for this pitch has not been created yet.
Read full article (1 min)